In general, the following guidelines can be applied: General Health Benefits For overall health and antioxidant support, a common dosage range for oral glutathione is between 250 to 1,000 mg per day

Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

It seeks to establish safety and efficacy before moving into human trials
10.1016/j.rbmo.2015.06.014 153
It is approved in Russia as a nootropic and neuroprotective drug (ischemic stroke, cognitive impairment)
Transient efficacy of tofacitinib in alopecia areata universalis